Ibogaine: A Miracle Psychedelic?

Science Vs49mMay 21, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Ibogaine: A Miracle Psychedelic?” inside PodZeus.

AI-Generated Summary

Ibogaine, a psychedelic derived from the iboga plant of West Africa, is being hailed as a potential miracle treatment for opioid addiction and PTSD—yet its risks are as intense as its promise. While patients like Rhett Chapman and Holly report life-changing experiences, including the dissolution of cravings and profound emotional healing, the drug’s long-term effectiveness is limited, with only about 30% of users staying opioid-free after two years. The real danger lies in its potential to cause fatal heart arrhythmias due to its effect on cardiac ion channels, a risk that has led to at least 30 documented deaths over decades. Despite promising short-term results in observational studies, clinical trials have failed to show clear benefits over placebo, and one high-dose trial used a reckless 1,800mg dose—10 times the safe level. Even when combined with DMT for a 'softer landing,' the science remains muddled. Experts now agree: Ibogaine is not a magic bullet. The safest path forward? Stick with better-studied, safer psychedelics like psilocybin in regulated clinical settings. The episode reveals a stark contrast between the raw, personal transformation some users describe and the sobering reality of a drug that can kill. While Ibogaine may open a door to healing, it demands extreme caution, professional oversight, and a commitment to ongoing recovery work.

Key Takeaways
1

Only 30% of people remained opioid-free two years after Ibogaine treatment, despite 80% reporting immediate relief from withdrawal symptoms.

2

Ibogaine can cause fatal heart arrhythmias by blocking potassium channels, with at least 30 documented deaths linked to the drug over decades.

3

No placebo-controlled clinical trial has proven Ibogaine’s effectiveness; one high-dose trial used 1,800mg—10 times the safe level—making it dangerously reckless.

4

Ibogaine is often paired with DMT in clinics to ease the psychological crash, but this complicates research and makes it impossible to isolate which drug drives the effect.

5

Experts recommend psilocybin therapy in regulated clinics over Ibogaine due to better safety data, proven efficacy, and professional oversight.

…and 3 more takeaways available in PodZeus

Chapters
0:00
10 min

The Ibogaine Hype and the Human Cost

I was dying. I felt like a dead walking person. I mean, a walking dead person. I was not living, let's put it that way.

Highlight
10:00
10 min

The Science Behind the Trip

Meryl Horn explains Ibogaine’s origins in the iboga plant of West Africa and its use in Bwiti religious rituals. She explores how psychedelics like Ibogaine affect the brain by altering neural communication, though the exact mechanism remains unclear. The episode highlights the drug’s intense, long-lasting trips—up to 20 hours—and the psychological intensity of reliving traumatic memories.

20:00
10 min

The Promising (But Flawed) Evidence

The main finding was that about 30% of people were still completely abstinent from opioids up to two years later.

Highlight
30:00
10 min

The Dark Side: Trauma, Healing, and the Need for Maintenance

Ibogaine will open the door for you, but you still have to walk through it.

Highlight
40:00
10 min

The Deadly Risk: Ibogaine and the Heart

There's no way a drug that was having those effects on the heart... fly. As a non-starter, FDA simply wouldn't approve it.

Highlight
High-Impact Quotes
I was dying. I felt like a dead walking person. I mean, a walking dead person. I was not living, let's put it that way.
Holly39:28
Viral: 88.0
If you are struggling and you really want to try a psychedelic, at the moment give magic mushrooms a go.
Meryl Horn42:40
Viral: 85.0
Ibogaine will open the door for you, but you still have to walk through it.
Rhett Chapman24:16
Viral: 78.0
Speakers

Host

Wendy Zuckerman

Guests

Meryl HornRhett ChapmanHollyAlan DavisPaul GlewRose Rimler
Topics Discussed
ibogaine for opioid addiction95%cardiac risks of psychedelics90%psilocybin therapy85%ibogaine and PTSD85%neuroplasticity and addiction80%ibogaine and DMT combination75%placebo-controlled trials75%psychedelic therapy clinics70%
People & Brands

Meryl Horn

person

15xNeutral

Wendy Zuckerman

person

12xNeutral

Rhett Chapman

person

10xPositive

Holly

person

8xPositive

Alan Davis

person

7xNeutral

Paul Glew

person

6xNeutral

noribogaine

other

6xNeutral

DMT

other

5xNeutral

iboga plant

product

5xNeutral

FDA

organization

5xNeutral

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Ibogaine: A Miracle Psychedelic?” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime